Bio Path Correlations

BPTH Stock  USD 0.80  0.02  2.44%   
The current 90-days correlation between Bio Path Holdings and Moleculin Biotech is 0.08 (i.e., Significant diversification). The correlation of Bio Path is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Bio Path Correlation With Market

Good diversification

The correlation between Bio Path Holdings and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving together with Bio Stock

  0.65EQ EquilliumPairCorr
  0.65PFE Pfizer Inc Aggressive PushPairCorr

Moving against Bio Stock

  0.67RNXT RenovoRxPairCorr
  0.53MDGL Madrigal PharmaceuticalsPairCorr
  0.38NXGLW NexGel WarrantPairCorr
  0.48T ATT Inc Sell-off TrendPairCorr
  0.43BAC Bank of America Aggressive PushPairCorr
  0.42CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.37JPM JPMorgan Chase Sell-off TrendPairCorr
  0.35INTC Intel Fiscal Year End 23rd of January 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BNTCCAPR
BLPHDFFN
BNTCCRNX
PULMCBIO
ALRNCAPR
CRNXCAPR
  
High negative correlations   
BLPHCAPR
BNTCBLPH
DFFNCBIO
CRNXBLPH
BLPHCBIO
CRNXDFFN

Risk-Adjusted Indicators

There is a big difference between Bio Stock performing well and Bio Path Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bio Path's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CBIO  4.25  1.10  0.12 (0.84) 4.45 
 9.76 
 38.47 
DFFN  2.40 (0.46) 0.00  1.07  0.00 
 4.09 
 12.34 
CAPR  6.80  2.66  0.50  16.70  4.10 
 18.22 
 69.31 
NXTC  2.57 (0.37) 0.00  1.85  0.00 
 5.22 
 21.68 
PULM  5.29  2.24  0.46 (4.44) 3.24 
 12.29 
 92.85 
BLPH  5.45 (1.92) 0.00  1.43  0.00 
 7.64 
 105.97 
CRNX  1.71 (0.01)(0.01) 0.11  2.43 
 3.67 
 16.75 
AMTI  5.08  0.11  0.01  0.29  5.70 
 11.11 
 36.60 
ALRN  4.20  0.22  0.03  0.92  4.69 
 8.06 
 41.47 
BNTC  3.26  0.25  0.04  1.54  3.49 
 7.89 
 29.78 

Bio Path Corporate Management

Michael MBAVP OperationsProfile
Alan MacKenzieConsultantProfile
Thomas WalkerConsultantProfile
MBA AshizawaDevelopment ResearchProfile
Peter MBAChairman, CoFounderProfile
Jeffery MDConsultantProfile
Victoria RacRegulatory ConsultantProfile